Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Yao-Min HungYu-Hsun WangLichi LinPaul Yung Pou WangJeng-Yuan ChiouJames Cheng-Chung WeiPublished in: International journal of clinical practice (2018)
This study revealed association of decreased CAD risk in RA patients taking HCQ. The protective effect of HCQ on CAD is consistent regarding subgroup analysis on age, gender and different comorbidities groups.
Keyphrases
- coronary artery
- end stage renal disease
- coronary artery disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis
- prognostic factors
- pulmonary artery
- peritoneal dialysis
- mental health
- single cell
- clinical trial
- systemic lupus erythematosus
- open label
- pulmonary hypertension
- double blind
- placebo controlled